Ask AI
ProCE Banner Activity

IO Combinations in First-line Advanced HCC: Current Evidence and Ongoing Trials

Slideset Download
Download this slideset from Ghassan K. Abou-Alfa, MD, MBA, to see the latest data on first-line immunotherapy treatment options for patients with advanced hepatocellular carcinoma.

Released: October 14, 2020

Expiration: October 13, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Program Director Disclosure

Program Director

Ghassan K. Abou-Alfa, MD

Assistant Attending Physician
Memorial Sloan Kettering Cancer Center
Assistant Professor
Weill Medical College at Cornell University
New York, New York

Ghassan K. Abou-Alfa, MD, MBA

Attending Physician
Memorial Sloan Kettering Cancer Center
New York, New York